You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
司太立(603520.SH):擬以3800萬元投資予君生物
格隆匯 11-26 17:48

格隆匯11月26日丨司太立(603520.SH)公佈,加快公司的產業佈局,增強在醫藥行業內的競爭力公司擬以自有資金3800萬元人民幣投資上海予君生物科技發展有限公司(“予君生物),此次投資完成後,公將持有予君生物9.0909%

予君生物是一家服務於創新藥與新材料領域的CRO/CDMO公司,長期專注主產品的技術積累和突破擅長多項特種技術,如烷基化技術,超低温反應,臭氧反應等,亦擅長新的連續流反應形式,且在金屬催化和酶催化技術的應用上具有豐富的經驗目前其處於持續投入期,未具備商業能力

予君生物當前的研發中心位於上海閔行,另有新建的一期3600平米,二期6700米的研發中心位於上海臨港,一期預計在2022年初投入使用,同時西安和武漢的研發中心也在籌備中現有員工47人,其中研發合成人23人(博士2人)核心團隊人員業務素質較高予君生物目前的研發項目以高技術壁壘的間體片段和原料藥為主

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account